NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Achieve Life Sciences, Inc. Share Price Chart

O H L

Achieve Life Sciences, Inc. Performance Overview

Days Range
$7.89Low
$7.93High

Markets Today

Previous Close$7.91
Open$7.93
Volume132,507
Day's Range$7.89 - $7.93
52W Range$2.62 - $8.64
Market Cap$763.54 M

Historical Performance

1M Returns+5.19
3M Returns+63.09
6M Returns+95.79
1Y Returns+175.61
5Y Returns-4.47
10Y ReturnsNA

Achieve Life Sciences, Inc. Fundamentals

Market Cap$763.54 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.58
EPS TTM$-1.55
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-54.65 M
Profit MarginN/A
Market Cap$763.54 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.58
EPS TTM$-1.55
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-54.65 M
Profit MarginN/A

Achieve Life Sciences, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$12.89 M-$12.66 M-$14.69 M-$15.14 M-$10.46 M-$18.49 M
EBITDA -$12.83 M-$12.61 M-$14.64 M-$14.67 M-$10.41 M-$18.43 M
Interest Expense -$185.00 K-$191.00 K-$192.00 K-$251.00 K-$274.00 K-$277.00 K
Depreciation $62.00 K$55.00 K$54.00 K$465.00 K$57.00 K$58.00 K
Income Before Tax -$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Net Profit Margin ------

Achieve Life Sciences, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $103.00 K$118.00 K$121.00 K$121.00 K$121.00 K$170.00 K
Reserve & Surplus -$218.40 M-$231.12 M-$245.56 M-$260.22 M-$270.39 M-$345.25 M
Non-Current Liabilities $9.95 M$8.69 M$8.70 M$11.19 M$10.59 M$7.46 M
Current Liabilities $7.13 M$8.57 M$9.73 M$9.08 M$11.83 M$197.66 M
Total Liabilities $17.08 M$17.27 M$18.43 M$20.27 M$22.43 M$205.12 M
Fixed Assets $918.00 K$863.00 K$807.00 K$751.00 K$696.00 K$809.00 K
Current Assets $25.00 M$56.90 M$50.05 M$39.89 M$31.06 M$188.29 M
Total Assets $27.36 M$58.94 M$52.04 M$41.79 M$33.10 M$190.44 M

Achieve Life Sciences, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$12.83 M-$12.72 M-$14.44 M-$14.66 M-$10.17 M-$74.77 M
Operating Cash Flow -$11.09 M-$9.07 M-$11.33 M-$17.98 M-$6.93 M-$10.78 M
Investing Cash Flow $11.35 M$6.70 M-$12.65 M$709.00 K$14.28 M-$137.80 M
Financing Cash Flow $0$41.22 M$4.04 M$6.26 M$21.00 K$168.46 M
Change in Cash $263.00 K$38.86 M-$19.94 M-$11.00 M$7.36 M$19.88 M

Achieve Life Sciences, Inc. Return Calculator

The Achieve Life Sciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$9,457
Invested Amount$10,000
Est. Returns$-543
Invest in USA Stock Today

About Achieve Life Sciences, Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

FAQs

Achieve Life Sciences, Inc. (ACHV) share price as of September 18, 2026 is $7.83. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Achieve Life Sciences, Inc. (ACHV) Share by opening an international trading account with Angel One.
Purchasing Achieve Life Sciences, Inc. (ACHV) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Achieve Life Sciences, Inc. (ACHV) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Achieve Life Sciences, Inc. (ACHV) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Achieve Life Sciences, Inc. on September 18, 2026, is $763.54 M.
Achieve Life Sciences, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Achieve Life Sciences, Inc. (ACHV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91